Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for 1 year was 2-6% higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. What's new? Policy-makers and health-care planners need accurate data on long-term survival to improve cancer control. This Europe-wide study of 10-year survival identified low survival in Eastern Europe for women with breast cancer in 2000-2002, and wide variation by age at diagnosis. Data on stage at diagnosis are crucial for meaningful comparison of population-based survival, and fundamental for improving breast cancer control, but our analyses confirmed that stage data are not collected routinely or consistently Copyright © 2012 UICC.

Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002

Ferretti, S.
Membro del Collaboration Group
;
2013

Abstract

Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for 1 year was 2-6% higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. What's new? Policy-makers and health-care planners need accurate data on long-term survival to improve cancer control. This Europe-wide study of 10-year survival identified low survival in Eastern Europe for women with breast cancer in 2000-2002, and wide variation by age at diagnosis. Data on stage at diagnosis are crucial for meaningful comparison of population-based survival, and fundamental for improving breast cancer control, but our analyses confirmed that stage data are not collected routinely or consistently Copyright © 2012 UICC.
2013
Allemani, Claudia; Minicozzi, Pamela; Berrino, Franco; Bastiaannet, Esther; Gavin, Anna; Galceran, Jaume; Ameijide, Alberto; Siesling, Sabine; Mangone, Lucia; Ardanaz, Eva; Hã©delin, Guy; Mateos, Antonio; Micheli, Andrea; Sant, Milena; Holub, J.; Jurickova, L.; Hakulinen, T.; Tryggvadottir, L.; Berrino, F.; Allemani, C.; Baili, P.; Ciampichini, R.; Ciccolallo, L.; Gatta, G.; Micheli, A.; Margutti, C.; Minicozzi, P.; Sant, M.; Sowe, S.; Tereanu, C.; Zigon, G.; Ferretti, S.; Federico, M.; Rashid, I.; Cirilli, C.; De Lisi, V.; Bozzani, F.; Tumino, R.; La Rosa, M. G.; Spata, E.; Sigona, A.; Falcini, F.; Foca, F.; Giorgetti, S.; Paci, E.; Crocetti, E.; Caldora, M.; Capocaccia, R.; Carrani, E.; De Angelis, R.; Francisci, S.; Grande, E.; Inghelmann, R.; Lenz, H.; Martina, L.; Roazzi, P.; Santaquilani, M.; Simonetti, A.; Tavilla, A.; Verdecchia, A.; Langmark, F.; Bray, F.; Johannesen, T. B.; Rachtan, J.; Gã³åºdåº, S.; Siudowska, U.; Mä å¼yk, R.; Bielska-Lasota, M.; Zwierko, M.; Safaei Diba, C.; PrimiÄ -Žakelj, M.; Klint, Ã. .; Talbã¤ck, M.; Usel, M.; Ess, S. M.; Lutz, J. M.; Pury, P.; Visser, O.; Greenberg, D. C.; Coleman, M. P.; Woods, L.; Forman, D.; Cooper, N.; Roche, M.; Lawrence, G.; Black, R. J.; Brewster, D. H.; Steward, J. A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2380569
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 54
social impact